Beyond Traditional Hyperthermia: In Vivo Cancer Treatment with Magnetic-Responsive Mesoporous Silica Nanocarriers

ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12518-12525. doi: 10.1021/acsami.8b02398. Epub 2018 Apr 3.

Abstract

In this study, we present an innovation in the tumor treatment in vivo mediated by magnetic mesoporous silica nanoparticles. This device was built with iron oxide magnetic nanoparticles embedded in a mesoporous silica matrix and coated with an engineered thermoresponsive polymer. The magnetic nanoparticles act as internal heating sources under an alternating magnetic field (AMF) that increase the temperature of the surroundings, provoking the polymer transition and consequently the release of a drug trapped inside the silica pores. By a synergic effect between the intracellular hyperthermia and chemotherapy triggered by AMF application, significant tumor growth inhibition was achieved in 48 h after treatment. Furthermore, the small magnetic loading used in the experiments indicates that the treatment is carried out without a global temperature rise of the tissue, which avoids the problem of the necessity to employ large amounts of magnetic cores, as is common in current magnetic hyperthermia.

Keywords: drug delivery; hot spot; magnetic hyperthermia; silica mesoporous nanoparticles; stimuli-responsive; synergic therapy; thermosensitive polymer.

MeSH terms

  • Humans
  • Hyperthermia, Induced
  • Magnetics
  • Nanoparticles
  • Neoplasms*
  • Polymers
  • Porosity
  • Silicon Dioxide

Substances

  • Polymers
  • Silicon Dioxide